VTRS Long Call Strategy

VTRS (Viatris Inc.), in the Healthcare sector, (Drug Manufacturers - Specialty & Generic industry), listed on NASDAQ.

Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, including noncommunicable and infectious diseases; biosimilars in the areas of oncology, immunology, endocrinology, ophthalmology, and dermatology; and APIs for antibacterial, central nervous system agents, antihistamines/antiasthmatics, cardiovascular, antivirals, antidiabetics, antifungals, and proton pump inhibitor areas, as well as support services, such as diagnostic clinics, educational seminars, and digital tools to help patients better manage their health. It provides its medicines in the form of oral solid doses, injectables, complex dosage forms, and APIs to retail and pharmacy establishments, wholesalers and distributors, payers, insurers and governments, and institutions. The company distributes its products through pharmaceutical wholesalers/distributors, pharmaceutical retailers, institutional pharmacies, mail-order and e-commerce pharmacies, and specialty pharmacies.

VTRS (Viatris Inc.) trades in the Healthcare sector, specifically Drug Manufacturers - Specialty & Generic, with a market capitalization of approximately $20.23B, a beta of 0.87 versus the broader market, a 52-week range of 8.19-17.53, average daily share volume of 11.3M, a public-listing history dating back to 1980, approximately 32K full-time employees. These structural characteristics shape how VTRS stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.

A beta of 0.87 places VTRS roughly in line with broader market moves, so the strategy payoff and realized volatility track the index-equivalent baseline. VTRS pays a dividend, which adjusts put-call parity and shifts the ex-dividend pricing across the listed chain.

What is a long call on VTRS?

A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration.

Current VTRS snapshot

As of May 15, 2026, spot at $16.54, ATM IV 32.40%, IV rank 3.30%, expected move 9.29%. The long call on VTRS below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 63-day expiry.

Why this long call structure on VTRS specifically: VTRS IV at 32.40% is on the cheap side of its 1-year range, which favors premium-buying structures like a VTRS long call, with a market-implied 1-standard-deviation move of approximately 9.29% (roughly $1.54 on the underlying). The 63-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated VTRS expiries trade a higher absolute premium for lower per-day decay. Position sizing on VTRS should anchor to the underlying notional of $16.54 per share and to the trader's directional view on VTRS stock.

VTRS long call setup

The VTRS long call below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With VTRS near $16.54, the first option leg uses a $17.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed VTRS chain at a 63-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 VTRS shares for the stock leg in covered calls and collars).

ActionTypeStrike / BasisPremium (est)
Buy 1Call$17.00$0.70

VTRS long call risk and reward

Net Premium / Debit
-$70.00
Max Profit (per contract)
Unbounded
Max Loss (per contract)
-$70.00
Breakeven(s)
$17.70
Risk / Reward Ratio
Unbounded

Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium.

VTRS long call payoff curve

Modeled P&L at expiration across a range of underlying prices for the long call on VTRS. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.

Underlying Price% From SpotP&L at Expiration
$0.01-99.9%-$70.00
$3.67-77.8%-$70.00
$7.32-55.7%-$70.00
$10.98-33.6%-$70.00
$14.63-11.5%-$70.00
$18.29+10.6%+$58.99
$21.95+32.7%+$424.59
$25.60+54.8%+$790.19
$29.26+76.9%+$1,155.78
$32.91+99.0%+$1,521.38

When traders use long call on VTRS

Long calls on VTRS express a bullish thesis with defined risk; traders use them ahead of VTRS catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.

VTRS thesis for this long call

The market-implied 1-standard-deviation range for VTRS extends from approximately $15.00 on the downside to $18.08 on the upside. A VTRS long call expresses a directional view that the underlying closes above the strike plus premium at expiration, ideally with implied volatility holding or expanding to preserve extrinsic value through the hold period. Current VTRS IV rank near 3.30% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on VTRS at 32.40%. As a Healthcare name, VTRS options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to VTRS-specific events.

VTRS long call positions are structurally bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. VTRS positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move VTRS alongside the broader basket even when VTRS-specific fundamentals are unchanged. Long-premium structures like a long call on VTRS are particularly exposed to IV-crush risk through scheduled events (earnings, FDA decisions, central-bank meetings) where IV typically contracts post-event regardless of the directional outcome. Always rebuild the position from current VTRS chain quotes before placing a trade.

Frequently asked questions

What is a long call on VTRS?
A long call on VTRS is the long call strategy applied to VTRS (stock). The strategy is structurally bullish: A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration. With VTRS stock trading near $16.54, the strikes shown on this page are snapped to the nearest listed VTRS chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
How are VTRS long call max profit and max loss calculated?
Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium. For the VTRS long call priced from the end-of-day chain at a 30-day expiry (ATM IV 32.40%), the computed maximum profit is unbounded per contract and the computed maximum loss is -$70.00 per contract. Live intraday quotes will differ as the chain moves through the trading session.
What is the breakeven for a VTRS long call?
The breakeven for the VTRS long call priced on this page is roughly $17.70 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current VTRS market-implied 1-standard-deviation expected move is approximately 9.29%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
When should you consider a long call on VTRS?
Long calls on VTRS express a bullish thesis with defined risk; traders use them ahead of VTRS catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.
How does current VTRS implied volatility affect this long call?
VTRS ATM IV is at 32.40% with IV rank near 3.30%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.

Related VTRS analysis